Masayoshi Koyama

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial ( <scp>EDITION JP</scp> 2)

Yasuo Terauchi, Masayoshi Koyama, Xi Cheng et al. · Diabetes Obesity and Metabolism · 2015 · 106 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Single‐dose new insulin glargine 300  <scp>U/ml</scp> provides prolonged, stable glycaemic control in <scp>J</scp> apanese and <scp>E</scp> uropean people with type 1 diabetes

Masanari Shiramoto, Takashi Eto, S. Irie et al. · Diabetes Obesity and Metabolism · 2014 · 94 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial ( <scp>EDITION JP</scp> 1)

Munehide Matsuhisa, Masayoshi Koyama, Xi Cheng et al. · Diabetes Obesity and Metabolism · 2015 · 85 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +12

Microgravity experiments of flame propagation in ethanol droplet-vapor-air mixture

Hiroshi Nomura, Masayoshi Koyama, Hideki Miyamoto et al. · Proceedings of the Combustion Institute · 2000 · 42 citations

Engineering, Aerospace Engineering, Physics +16

Sustained glycaemic control and less nocturnal hypoglycaemia with insulin glargine 300U/mL compared with glargine 100U/mL in Japanese adults with type 1 diabetes (EDITION JP 1 randomised 12-month trial including 6-month extension)

Munehide Matsuhisa, Masayoshi Koyama, Xi Cheng et al. · Diabetes Research and Clinical Practice · 2016 · 32 citations

Medicine, Endocrinology, Pharmacotherapy +15